MedTrace Logo

ALBI and PALBI Scores and HCC Prognosis

NCT05720195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 645

Last updated 2023-02-09

No results posted yet for this study

Summary

To compare the predictive ability of ALBI and PALBI grades with CTP and MELD scores.

To investigate the efficacy of ALBI and PALBI grades for predicting the prognosis of HCC and overall survival among different modalities of treatment.

Conditions

  • Hepatocellular Carcinoma (HCC) Prognosis

Interventions

DIAGNOSTIC_TEST

ALBI

Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades for prognosis of HCC

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05720195 on ClinicalTrials.gov